# A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension

Study · id `cardio:ct-nct01642498` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01642498](<https://clinicaltrials.gov/study/NCT01642498>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01642498

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01642498. Randomized; no masking; primary purpose treatment. Start 2012-09-01 (actual); primary completion 2018-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01642498, source copy `cardio:ctgov-nct01642498-2019-05-10`, retrieved 2026-10-26)
- Started: 2012-09-01 (actual) (ClinicalTrials.gov record NCT01642498, source copy `cardio:ctgov-nct01642498-2019-05-10`, retrieved 2026-10-26)
- Primary completion: 2018-06-30 (actual) (ClinicalTrials.gov record NCT01642498, source copy `cardio:ctgov-nct01642498-2019-05-10`, retrieved 2026-10-26)
- Completion: 2018-06-30 (actual) (ClinicalTrials.gov record NCT01642498, source copy `cardio:ctgov-nct01642498-2019-05-10`, retrieved 2026-10-26)
- Countries: Belgium; Germany; Greece; Ireland; Netherlands; Poland; United Kingdom (ClinicalTrials.gov record NCT01642498, source copy `cardio:ctgov-nct01642498-2019-05-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01642498-2019-05-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension
- Condition: Hypertension
- Intervention (Device): ROX COUPLER
- Lead sponsor: ROX Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Resistant hypertension (`cardio:resistant-hypertension`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 4fc4be5a69cda1ec586e193a3e49a9d739f32141cf258c1e9b67ee436b09fb67
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
